Can Preconditioning Cornea Improves Transplant Success?
July 11, 2010
Submit Comments
According to research reported on MedPage Today, topical treatments to “precondition” the corneal bed before transplantation may help the new cornea to succeed. Researchers cautioned that this “preconditioning” effect still needs to be tested in trials by topical application of vascular endothelial growth factor (VEGF) inhibitors, such as bevacizumab (Avastin), ranibizumab (Lucentis), or novel agents.
Read the full story on MedPage Today.
You might also enjoy...
- Do Anti-VEGF Injections Increase the Risk of Stroke or Heart Attack?
- Avastin vs. Lucentis: The Origin of the Debate
- Study Finds No Difference Between Avastin and Lucentis in Treatment of AMD
- CATT Study Finds No Difference Between Avastin and Lucentis in Stopping Progression of Wet Macular Degeneration
- Can Blocking of microRNA Offer a New Treatment of Macular Degeneration?
Comments
Jump down to form below to submit your own comments
